Understanding the GP Data Extraction Scheme & Use of Patient Data

The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...

3 days ago
Clinical Development,Clinical Operations,Data,News

Understanding the GP Data Extraction Scheme & Use of Patient Data

The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...

3 days ago

How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?

As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...

7 days ago
Oncology,Clinical Operations,Biology,News

How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?

As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...

7 days ago

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...

2 weeks ago
R&D,Clinical Development,Biology,News

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...

2 weeks ago

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

2 weeks ago
Clinical Operations,Race and Ethics,Precision and Personalised Medicine,Biology,News

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

2 weeks ago

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

3 weeks ago
Clinical Operations,AI & ML

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

3 weeks ago

The Impact of Modern Technology on Clinical Operations

The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...

4 weeks ago
Bioinformatics,Clinical Operations,AI & ML,Biology,News

The Impact of Modern Technology on Clinical Operations

The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...

4 weeks ago

Real World Data and Evidence: Emerging Trends Across Clinical Research

Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...

1 month ago
Bioinformatics,Clinical Operations,Biology,News

Real World Data and Evidence: Emerging Trends Across Clinical Research

Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...

1 month ago

Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs

Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...

1 month ago
Oncology,Clinical Operations,Biology,News

Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs

Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...

1 month ago

The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer

In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases -  paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...

2 months ago
Clinical Development,Clinical Operations,Precision and Personalised Medicine,Biology,News

The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer

In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases -  paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...

2 months ago

Optimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries

Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...

2 months ago
Oncology,Clinical Development,Biology,News

Optimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries

Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...

2 months ago